Virtu Financial’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Virtu Financial’s Portfolio BSPM Stock Details BSPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,186	Closed	-$25K	–	3089
2017 Q4	$25K	Buy	+14,186	New	+$25.2K	﹤0.01%	2195

Other funds holding BSPM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu Financial's BSPM Position: Q1 2018 in Review

Virtu Financial sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q1 2018, closing a stake of 14,186 shares — an estimated $25K sold.

Virtu Financial first reported a position in BSPM in Q4 2017 and held it in 1 quarter. The position peaked at $25K in Q4 2017. 4 funds tracked by Wall St. Rank hold BSPM as of Q1 2018.

Virtu Financial reported no remaining Biostar Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Virtu Financial sold 14,186 Biostar Pharmaceuticals, Inc. shares in Q1 2018, an estimated $25K.
Virtu Financial first reported a position in Biostar Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
Virtu Financial's Biostar Pharmaceuticals, Inc. position peaked at $25K in Q4 2017.
4 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q1 2018.

Based on Virtu Financial's 13F filing for Q1 2018, filed 14 May 2018.